{"id":8553,"date":"2023-11-14T00:48:00","date_gmt":"2023-11-14T06:48:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/education\/changing-the-strategy-introduction-of-the-120-pulse-shockwave-c2-plus-catheter\/"},"modified":"2024-12-11T09:16:37","modified_gmt":"2024-12-11T15:16:37","slug":"changing-the-strategy-introduction-of-the-120-pulse-shockwave-c2-plus-catheter","status":"publish","type":"post","link":"https:\/\/shockwavemedical.com\/en-eu\/education\/changing-the-strategy-introduction-of-the-120-pulse-shockwave-c2-plus-catheter\/","title":{"rendered":"Changing the Strategy: Introduction of the 120-Pulse Shockwave C2+ Catheter"},"content":{"rendered":"\n<section id=\"block_91500a1081f8d2b5a71e45012f86f27c\" class=\"block block--wysiwyg wysiwyg_styles u-bgColorNone container\">\n\t<div class=\"u-wysiwyg u-animation\">\n\t\t<p>Dr. Ziad Ali of St. Francis Hospital and Heart Center, Roslyn, New York explains the concept behind the development of the Shockwave C2+ catheter to facilitate the management of more complex, calcified lesions leading to a paradigm shift from lesion prep to vessel prep. Dr. Ali also shares his initial experiences with Shockwave C2+ including his pulse management strategy with 40 additional pulses to better treat long diffuse lesions as well as multiple calcium morphologies including eccentric and nodular calcium.<\/p>\n<p>Download the <a href=\"https:\/\/shockwavemedical.com\/wp-content\/uploads\/2024\/11\/SPL-70449-Rev-A-Ziad-Ali-C2-CLD-Article.pdf\" target=\"_blank\" rel=\"noopener\">PDF<\/a>\u00a0or read The Calcium Corner\u00a0<a href=\"https:\/\/www.hmpgloballearningnetwork.com\/site\/cathlab\/calcium-corner\/changing-strategy-introduction-120-pulse-shockwave-c2-catheter-st\" target=\"_blank\" rel=\"noopener\">online here<\/a>.<\/p>\n<p>This article was developed in collaboration with Cath Lab Digest to bring you the latest calcium insights from the U.S. coronary interventional experts who know it best. The Calcium Corner, contains a series of articles where operators share their perspective on the challenges and treatment of coronary artery calcium. Read about experts\u2019 clinical experience, case studies and treatment algorithms with Coronary IVL \u2013 hope you enjoy the content.<\/p>\n<hr \/>\n<p><span class=\"legal_copy\">Dr. Ziad Ali is a paid consultant of Shockwave Medical.<\/span><\/p>\n<p><strong><span class=\"legal_copy\">Coronary Important Safety Information:<\/span><\/strong><\/p>\n<p><span class=\"legal_copy\"> In the United States: Rx only.<\/span><\/p>\n<p><span class=\"legal_copy\"> Indications for Use\u2014The Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2\u00a0Coronary IVL Catheter is indicated for lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic\u00a0de novo\u00a0coronary arteries prior to stenting. <\/span><\/p>\n<p><span class=\"legal_copy\">Contraindications\u2014The Shockwave C2\u00a0Coronary IVL System is contraindicated for the following: This device is not intended for stent delivery. This device is not intended for use in carotid or cerebrovascular arteries. <\/span><\/p>\n<p><span class=\"legal_copy\">Warnings\u2014 Use the IVL Generator in accordance with recommended settings as stated in the Operator\u2019s Manual. The risk of a dissection or perforation is increased in severely calcified lesions undergoing percutaneous treatment, including IVL. Appropriate provisional interventions should be readily available. Balloon loss of pressure was associated with a numerical increase in dissection which was not statistically significant and was not associated with MACE.\u00a0 Analysis indicates calcium length is a predictor of dissection and balloon loss of pressure.\u00a0 IVL generates mechanical pulses which may cause atrial or ventricular capture in bradycardic patients. In patients with implantable pacemakers and defibrillators, the asynchronous capture may interact with the sensing capabilities. Monitoring of the electrocardiographic rhythm and continuous arterial pressure during IVL treatment is required.\u00a0 In the event of clinically significant hemodynamic effects, temporarily cease delivery of IVL therapy. <\/span><\/p>\n<p><span class=\"legal_copy\">Precautions\u2014 Only to be used by physicians trained in angiography and intravascular coronary procedures. Use only the recommended balloon inflation medium. Hydrophilic coating to be wet only with normal saline or water and care must be taken with sharp objects to avoid damage to the hydrophilic coating.\u00a0Appropriate anticoagulant therapy should be administered by the physician.\u00a0Precaution should be taken when treating patients with previous stenting within 5mm of target lesion. <\/span><\/p>\n<p><span class=\"legal_copy\">Potential adverse effects consistent with standard based cardiac interventions include\u2013 Abrupt vessel closure \u2013 Allergic reaction to contrast medium, anticoagulant and\/or antithrombotic therapy-Aneurysm-Arrhythmia-Arteriovenous fistula-Bleeding complications-Cardiac tamponade or pericardial effusion-Cardiopulmonary arrest-Cerebrovascular accident (CVA)-Coronary artery\/vessel occlusion, perforation, rupture or dissection-Coronary artery spasm-Death-Emboli (air, tissue, thrombus or atherosclerotic emboli)-Emergency or non-emergency coronary artery bypass surgery-Emergency or non-emergency percutaneous coronary intervention-Entry site complications-Fracture of the guide wire or failure\/malfunction of any component of the device that may or may not lead to device embolism, dissection, serious injury or surgical intervention-Hematoma at the vascular access site(s)-Hemorrhage-Hypertension\/Hypotension-Infection\/sepsis\/fever-Myocardial Infarction-Myocardial Ischemia or unstable angina-Pain-Peripheral Ischemia-Pseudoaneurysm-Renal failure\/insufficiency-Restenosis of the treated coronary artery leading to revascularization-Shock\/pulmonary edema-Slow flow, no reflow, or abrupt closure of coronary artery-Stroke-Thrombus-Vessel closure, abrupt-Vessel injury requiring surgical repair-Vessel dissection, perforation, rupture, or spasm. Risks identified as related to the device and its use:\u00a0Allergic\/immunologic reaction to the catheter material(s) or coating-Device malfunction, failure, or balloon loss of pressure leading to device embolism, dissection, serious injury or surgical intervention-Atrial or ventricular extrasystole-Atrial or ventricular capture. <\/span><\/p>\n<p><span class=\"legal_copy\">Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events.\u00a0\u00a0<a href=\"https:\/\/shockwavemedical.com\/en-eu\/ifu\/\">https:\/\/shockwavemedical.com\/IFU <\/a><\/span><\/p>\n<p><span class=\"legal_copy\">Please contact your local Shockwave representative for specific country availability and refer to the Shockwave C2\u00a0instructions for use containing important safety information.<\/span><\/p>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"<p>Dr. Ziad Ali walks us through his pulse management with the additional 40 pulses of Shockwave C2+<\/p>\n","protected":false},"author":2,"featured_media":10690,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":[203],"meta":{"_acf_changed":true,"content-type":"","footnotes":""},"categories":[1,17],"tags":[],"disease-state":[159],"education-topic":[183,191,195],"product-tag":[251],"specialty":[295,328,332,336,340,344],"technology":[316],"class_list":["post-8553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","category-uncategorized-en-uk","disease-state-coronary-artery-disease-en-uk","education-topic-best-practices-en-uk","education-topic-mechanism-of-action-moa","education-topic-peer-to-peer-en-uk","format-article-en-uk","product-tag-shockwave-c2-en-uk","specialty-fellows-residents-en-uk","specialty-interventional-cardiologists-en-uk","specialty-interventional-radiologists-en-uk","specialty-nurses-technologists-en-uk","specialty-patients-caregivers","specialty-vascular-surgeons-en-uk","technology-coronary-ivl-en-uk"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts\/8553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/comments?post=8553"}],"version-history":[{"count":0,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts\/8553\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/media\/10690"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/media?parent=8553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/categories?post=8553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/tags?post=8553"},{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/disease-state?post=8553"},{"taxonomy":"education-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/education-topic?post=8553"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/format?post=8553"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/product-tag?post=8553"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/specialty?post=8553"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/technology?post=8553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}